27 May 2024 : Clinical Research
Percutaneous Coronary Intervention as a Non-Surgical Treatment for Ischemic Mitral Regurgitation in Patients with Multi-Vessel Coronary Artery Disease
Xiaoyan Wang
1ABCE*, Zhihong Liu 1ABCDE, Aoyun Rong 1ABDE, Bofei Ma 1BCDE, Ruixing Mo 1BCEG
DOI: 10.12659/MSM.943122
Med Sci Monit 2024; 30:e943122
Table 5 Comparison of echocardiographic parameters in patients before and after treatment.
| Parameters | Before procedure | One month after surgery | One year after surgery |
|---|---|---|---|
| LAAD (mm) | 35.60±3.58 | 37.70±3.06 | 37.13±2.53 |
| LVIDd (mm) | 48.20±3.91 | 49.40±2.92 | 49.80±2.76 |
| LVIDs (mm) | 32.20±3.73 | 33.93±3.43 | 34.00±2.67 |
| LVEF | 60.60±6.39 | 61.53±3.58 | 61.00±2.30 |
| LVFS | 33.13±4.61 | 31.53±3.92 | 31.53±3.33 |
| MR area (cm) | 7.19±1.71 | 2.73±0.69 | 2.26±0.58 |
| WMA (n, %) | |||
| Anterior wall | 3 (20.00) | 1 (6.67) | 0 (0.00) |
| Inferior wall | 6 (40.00) | 0 (0.00) | 0 (0.00) |
| Posterior wall | 3 (20.00) | 0 (0.00) | 0 (0.00) |
| LAAD – left atrial anteroposterior diameter; LVIDd – left ventricle internal diameter in diastole; LVIDs – left ventricular internal diameter at end-systole; LVEF – left ventricular ejection fraction; LVFS – left ventricular fractional shortening; MR – mitral regurgitation; WMA – wall motion abnormality. | |||